PMP22 and hereditary neuropathy with liability to pressure palsies: As a consequence, one additional copy of PMP22 is responsible for CMT1A, whereas loss of one copy of PMP22 results in HNPP, highlighting a gene dosage effect as the mechanism for these disorders [45].